Oscar Health Class A (OSCR) closed at $33.18 on November 5, 2026, down 5.7% from the previous close, on volume of 9,648,374 shares (30-day average 4,819,089).
Data as of November 5, 2026.
Oscar Health (OSCR) Receives a Buy from Piper Sandler
TipRanks (Fri, 6-Nov 9:16 AM ET)
Barclays Sticks to Its Buy Rating for Oscar Health (OSCR)
TipRanks (Fri, 6-Nov 4:11 AM ET)
Oscar Health raises 2026 outlook for earnings from operations after Q3 swings to profit
Market Chameleon (Thu, 5-Nov 2:16 AM ET)
Oscar Health GAAP EPS of $0.49 beats by $0.66, revenue of $5.14B beats by $420M
Seeking Alpha News (Thu, 5-Nov 6:05 AM ET)
Oscar Health Announces Financial Results for Third Quarter 2026 and Raises Full Year 2026 Outlook
Business Wire (Thu, 5-Nov 6:00 AM ET)
Here are the major earnings before the open Thursday
Seeking Alpha News (Wed, 4-Nov 6:00 PM ET)
Oscar Health Q3 2026 Earnings Preview
Seeking Alpha News (Wed, 4-Nov 3:48 PM ET)
Blue wave lifts hospital stocks, health insurers
Seeking Alpha News (Wed, 4-Nov 12:50 PM ET)
At a glance: stocks gapping up premarket
Seeking Alpha News (Wed, 4-Nov 7:02 AM ET)
How health care is on the ballot in the midterms
Seeking Alpha News (Tue, 3-Nov 12:13 PM ET)
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
Oscar Health Class A trades on the NYSE stock market under the symbol OSCR.
As of November 6, 2026, OSCR stock price declined to $31.40 with 1,347,117 million shares trading.
OSCR has a beta of 2.23, meaning it tends to be more sensitive to market movements. OSCR has a correlation of 0.15 to the broad based SPY ETF.
OSCR has a market cap of $9.69 billion. This is considered a Mid Cap stock.
Last quarter Oscar Health Class A reported $5 billion in Revenue and $.49 earnings per share. This beat revenue expectation by $421 million and exceeded earnings estimates by $.65.
In the last 3 years, OSCR traded as high as $38.50 and as low as $5.65.
The top ETF exchange traded funds that OSCR belongs to (by Net Assets): VTI, IWM, VB, AVUV, VBK.
OSCR has outperformed the market in the last year with a return of +84.4%, while the SPY ETF gained +10.3%. In the last 3 month period, OSCR beat the market returning +4.3%, while SPY returned -3.7%. However, in the most recent 2 weeks OSCR has underperformed the stock market by returning -5.8%, while SPY returned -3.2%.
OSCR support price is $32.14 and resistance is $34.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSCR shares will trade within this expected range on the day.